Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer

Survival of breast cancer patients has improved, and treatment-related changes regarding metabolic profile deterioration after neoadjuvant systemic treatment (NST) become important issues in cancer survivors. We sought to compare metabolic profile changes and the neutrophil-to-lymphocyte ratio (NLR)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Ryu, Ho Hyun, Ahn, Sei Hyun, Kim, Seon Ok, Kim, Jeong Eun, Kim, Ji sun, Ahn, Jin-Hee, Jung, Kyung Hae, Kim, Sung-Bae, Ko, Beom Seok, Lee, Jong Won, Son, Byung Ho, Shin, Hee Jung, Kim, Hak Hee, Gong, Gyung yub, Kim, Hee Jeong
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8131718/
https://ncbi.nlm.nih.gov/pubmed/34006898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-89651-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares